naltrexone has been researched along with Dissociation in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Enning, F; Schmahl, C | 1 |
Benito, A; Escamilla, I; Haro, G; Juan, N; Peñalva, C; Renau, J; Sánchez-Llorens, M | 1 |
García, MC | 1 |
Pape, W; Wöller, W | 1 |
Böhme, R; Bohus, MJ; Landwehrmeyer, GB; Limberger, MF; Schmahl, CG; Stiglmayr, CE | 1 |
Bohus, M; Schmahl, C | 1 |
Bolm, T; Piegler, T | 1 |
2 review(s) available for naltrexone and Dissociation
Article | Year |
---|---|
Treatment of dissociative symptoms with opioid antagonists: a systematic review.
Topics: Dissociative Disorders; Humans; Naloxone; Naltrexone; Narcotic Antagonists | 2023 |
[Treatment of borderline personality disorder with opioid antagonists: buprenorphine, nalmefene, naloxone and naltrexone in the treatment of dissociative symptoms, self-mutilation and suicidal behavior].
Topics: Borderline Personality Disorder; Buprenorphine; Dissociative Disorders; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Observational Studies as Topic; Self Mutilation; Suicidal Ideation | 2020 |
1 trial(s) available for naltrexone and Dissociation
Article | Year |
---|---|
Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial.
Topics: Adolescent; Adult; Borderline Personality Disorder; Comorbidity; Dissociative Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Germany; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Personality Inventory; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 1999 |
4 other study(ies) available for naltrexone and Dissociation
Article | Year |
---|---|
[Treatment of dissociative symptoms with nalmefene in patients with borderline personality disorder and complex posttraumatic stress disorder].
Topics: Borderline Personality Disorder; Dissociative Disorders; Humans; Naltrexone; Stress Disorders, Post-Traumatic | 2022 |
[Low dose naltrexone in the treatment of dissociative symptoms].
Topics: Adult; Dissociative Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Satisfaction; Stress Disorders, Post-Traumatic; Treatment Outcome | 2015 |
[Treatment of dissociative symptoms in borderline personality disorder with naltrexone: supplementary comments].
Topics: Borderline Personality Disorder; Dissociative Disorders; Drug Administration Schedule; Female; Humans; Naltrexone; Narcotic Antagonists; Self-Injurious Behavior; Treatment Outcome | 2000 |
[Naltrexone in the treatment of dissociative disorders--reflections with regard to a comprehensive therapeutic concept of borderline disorders].
Topics: Adult; Borderline Personality Disorder; Combined Modality Therapy; Depression; Dissociative Disorders; Female; Humans; Naltrexone; Narcotic Antagonists; Psychotherapeutic Processes; Psychotherapy; Self-Injurious Behavior; Stress Disorders, Post-Traumatic; Treatment Outcome | 2001 |